Latest Breaking News On - ஆராய்ச்சி பயன்பாடு மட்டும் - Page 1 : vimarsana.com

SpeeDx Expand SARS-CoV-2 Variant Analysis Pipeline

SpeeDx Expand SARS-CoV-2 Variant Analysis Pipeline
ibtimes.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ibtimes.com.au Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomSpeedx ptyColin denverDivision of viral diseasesResearch useNational centerResearch use onlyRespiratory diseasesநகரம் ஆஃப்ஒன்றுபட்டது கிஂக்டம்கொலின் டென்வர்பிரிவு ஆஃப் வைரஸ் நோய்கள்ஆராய்ச்சி பயன்பாடுதேசிய மையம்ஆராய்ச்சி பயன்பாடு மட்டும்

How LC-MS Can Support SARS-CoV-2 Research

In this interview, Kevin Wyndham, senior director of research and development at Waters, highlights how a new LC-MS method could be used to support research both during and beyond the COVID-19 pandemic.

United kingdomCity ofMaarten dhaenenKevin wyndhamLeigh andersonUniversity college londonUniversity of southamptonKings college londonLeeds universityUniversity of leicesterResearch use onlyUniversity of manchesterGhent universityHarvard school of public healthImperial college londonNational health services

SpeeDx Launch Solution for SARS-CoV-2 Variant Analysis

SpeeDx Launch Solution for SARS-CoV-2 Variant Analysis
ibtimes.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ibtimes.com.au Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomSpeedx ptyElisa mokanyTechnology officerDivision of viral diseasesResearch useNational centerSpeedx chief technologyResearch use onlyRespiratory diseasesநகரம் ஆஃப்ஒன்றுபட்டது கிஂக்டம்தொழில்நுட்பம் அதிகாரிபிரிவு ஆஃப் வைரஸ் நோய்கள்ஆராய்ச்சி பயன்பாடு

Yale Cancer Center Study Shows Novel Test Can Detect New and Recurrent Bladder Cancer

/PRNewswire/ A study led by researchers at Yale Cancer Center, Stony Brook University, and KDx Diagnostics, Inc., examined a revolutionary new urine.

Rhode islandUnited statesNamw kimLuisa escobar hoyosKdx diagnostics incSmilow cancer hospital care centersYale cancer centerResearch useStony brook universityNational cancerSource kdx diagnostics incAmerican cancer societyAmerican journalAssistant professorTherapeutic radiologyChief executive officer

Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) toAdvance Clinical Research of Infectious Diseases

Waters Corporation (NYSE:WAT) today introduced a new RUO LC-MS test method to advance critical infectious disease research. Waters™ SARS-CoV-2 LC-MS Kit (RUO) uses an orthogonal analytical method that directly detects and quantifies SARS-CoV-2 Nucleocapsid (NCAP) peptides that initial studies have shown to yield highly accurate, quantitative results.

United statesUnited kingdomChris orlandoUnited kingdom national health serviceCorporate communicationsResearch use onlyA communityAnderson forschung groupWaters corporationBusiness wireUdit batraNational health serviceAssay technologiesI class plus systemPipetting robotCommunity based template assay